Nadir creatinine predicts long-term bladder function in boys with posterior urethral valves.


Journal

Journal of pediatric urology
ISSN: 1873-4898
Titre abrégé: J Pediatr Urol
Pays: England
ID NLM: 101233150

Informations de publication

Date de publication:
04 2022
Historique:
received: 10 11 2021
revised: 26 01 2022
accepted: 28 01 2022
pubmed: 22 2 2022
medline: 7 6 2022
entrez: 21 2 2022
Statut: ppublish

Résumé

Posterior urethral valves (PUV) cause lower urinary tract obstruction leading to increased intravesical pressure during fetal urinary tract development. Though the bladder and kidneys are separate organs, with different embryological origins, they are complementary and influence each other both before and after birth. We aimed to assess the relationship between renal and bladder function in boys with PUV and whether early renal markers could predict future bladder function. We included all boys with prenatally suspected lower urinary tract obstruction, born between 2000 and 2013, in two University Hospitals, with at least 5 years follow-up. We excluded patients who presented a Lower Urinary Tract Obstruction other than PUV, children who presented multiple birth defects and neonatal deaths and those with incomplete long-term renal or bladder function data. We included data on nadir creatinine (NC), long-term renal function and long-term bladder function (defined by Uroflow parameters). Boys with PUV were divided into three severity groups for renal function according to their NC and three severity groups for bladder function as determined by Uroflow. We included 73 boys. Average nadir creatinine was 43.4 ± 26.1 μmol/L. Twenty-nine boys (49.3%) presented a NC < 35 μmol/L, thirty-eight (52.1%) a NC between 35 and 75 μmol/L, and 6 (8.2%) a NC > 75 μmol/L. Thirty-eight (52.1%) presented normal bladder function, 23 (31.5%) presented moderately impaired bladder function and 12 (16.4%) presented severely impaired bladder function. 41.4% of boys with NC < 35 had abnormal bladder function vs 46.2% of those with an NC between 35 and 75 μmol/L and 83.3% of boys with NC > 75 μmol/L. Nadir creatinine both predicted both bladder function and renal status (table 1). Correlation between presence of grade 3-5 CKD and poor uroflow was also significant (p < 0.005). Nadir creatinine was significantly correlated to bladder function at 5 years of age. What this study suggests is that as nadir creatinine increases so does the risk of severe bladder dysfunction. Our results, though limited to flowmeter and renal function, could help pediatric urologist tailor bladder function monitoring, and indicate which patients could benefit from more aggressive bladder therapy. Bladder and renal function are linked in boys with posterior urethral valves. Boys with high nadir creatinine could benefit from early bladder function evaluation and management.

Identifiants

pubmed: 35184944
pii: S1477-5131(22)00054-7
doi: 10.1016/j.jpurol.2022.01.017
pii:
doi:

Substances chimiques

Creatinine AYI8EX34EU

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

186.e1-186.e4

Informations de copyright

Copyright © 2022 Journal of Pediatric Urology Company. Published by Elsevier Ltd. All rights reserved.

Auteurs

T Delefortrie (T)

Department of Pediatric Surgery and Urology, Hôpital Universitaire Robert Debré, APHP, Université de Paris, Paris, France; Department of Pediatric Surgery, CHU F Guyon, Saint-Denis de La Réunion, France; Department of Pediatric Surgery, CHU Pellegrin-Enfants, Bordeaux, France; Centre de Référence des Malformations Rares des Voies Urinaires (MARVU), France.

C Ferdynus (C)

Unité de Soutien Méthodologique, CHU F Guyon, Saint-Denis de La Réunion, France.

A Paye-Jaouen (A)

Department of Pediatric Surgery and Urology, Hôpital Universitaire Robert Debré, APHP, Université de Paris, Paris, France; Centre de Référence des Malformations Rares des Voies Urinaires (MARVU), France.

M Peycelon (M)

Department of Pediatric Surgery and Urology, Hôpital Universitaire Robert Debré, APHP, Université de Paris, Paris, France; Centre de Référence des Malformations Rares des Voies Urinaires (MARVU), France.

J L Michel (JL)

Department of Pediatric Surgery, CHU F Guyon, Saint-Denis de La Réunion, France.

E Dobremez (E)

Department of Pediatric Surgery, CHU Pellegrin-Enfants, Bordeaux, France.

A El Ghoneimi (A)

Department of Pediatric Surgery and Urology, Hôpital Universitaire Robert Debré, APHP, Université de Paris, Paris, France; Centre de Référence des Malformations Rares des Voies Urinaires (MARVU), France.

L Harper (L)

Department of Pediatric Surgery, CHU Pellegrin-Enfants, Bordeaux, France. Electronic address: harper_luke@hotmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH